BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17804235)

  • 21. Pulmonary metastases of breast cancer. When is resection indicated?
    Welter S; Jacobs J; Krbek T; Tötsch M; Stamatis G
    Eur J Cardiothorac Surg; 2008 Dec; 34(6):1228-34. PubMed ID: 18824371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation of body mass index (BMI) to disease free (DFS) and distant disease free survivals (DDFS) among Turkish women with operable breast carcinoma.
    Demirkan B; Alacacioglu A; Yilmaz U
    Jpn J Clin Oncol; 2007 Apr; 37(4):256-65. PubMed ID: 17553816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
    J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Casting-type calcifications on the mammogram suggest a higher probability of early relapse and death among high-risk breast cancer patients.
    Pálka I; Ormándi K; Gaál S; Boda K; Kahán Z
    Acta Oncol; 2007; 46(8):1178-83. PubMed ID: 17851833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STK15/Aurora-A expression in primary breast tumors is correlated with nuclear grade but not with prognosis.
    Royce ME; Xia W; Sahin AA; Katayama H; Johnston DA; Hortobagyi G; Sen S; Hung MC
    Cancer; 2004 Jan; 100(1):12-9. PubMed ID: 14692019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postmastectomy locoregional recurrence and distant metastasis in breast carcinoma patients.
    Yildirim E; Berberoglu U
    Breast; 2008 Aug; 17(4):367-71. PubMed ID: 18472419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local recurrence after mastectomy in patients with T3pN0 breast carcinoma treated without postoperative radiation therapy.
    Mignano JE; Gage I; Piantadosi S; Ye X; Henderson G; Dooley WC
    Am J Clin Oncol; 2007 Oct; 30(5):466-72. PubMed ID: 17921705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
    Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
    J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
    Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c.
    Kyndi M; Overgaard M; Nielsen HM; Sørensen FB; Knudsen H; Overgaard J
    Radiother Oncol; 2009 Jan; 90(1):74-9. PubMed ID: 18471914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting distant dissemination in patients with early breast cancer.
    Arriagada R; Rutqvist LE; Johansson H; Kramar A; Rotstein S
    Acta Oncol; 2008; 47(6):1113-21. PubMed ID: 18607866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival.
    Bafford AC; Burstein HJ; Barkley CR; Smith BL; Lipsitz S; Iglehart JD; Winer EP; Golshan M
    Breast Cancer Res Treat; 2009 May; 115(1):7-12. PubMed ID: 18581232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
    Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features and outcome of the tall cell variant of papillary thyroid carcinoma.
    Leung AK; Chow SM; Law SC
    Laryngoscope; 2008 Jan; 118(1):32-8. PubMed ID: 18025951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel node biopsy in larger or multifocal breast cancers: to do or not to do.
    Behm EC; Buckingham JM
    ANZ J Surg; 2008 Mar; 78(3):151-7. PubMed ID: 18269478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapy.
    D'Alessandro C; Dellapasqua S; Orlando L; Santoro L; Maisonneuve P; Torrisi R; Balduzzi A; Scarano E; Ghisini R; Peruzzotti G; Goldhirsch A; Colleoni M
    Breast J; 2008; 14(5):435-41. PubMed ID: 18821931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Which is the better pathological prognostic factor, the Nottingham histological grade or the Japanese nuclear grade? A large scale study with a long-term follow-up.
    Otsuki Y; Shimizu S; Suwa K; Yoshida M; Kanzaki M; Kobayashi H
    Jpn J Clin Oncol; 2007 Apr; 37(4):266-74. PubMed ID: 17553817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.